Abstract
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery
Title: Patent Selections
Volume: 1 Issue: 3
Author(s): Bentham Science Publishers
Affiliation:
Abstract:
Export Options
About this article
Cite this article as:
Bentham Science Publishers , Patent Selections, Recent Patents on Endocrine, Metabolic & Immune Drug Discovery 2007; 1 (3) . https://dx.doi.org/10.2174/187221407782409134
DOI https://dx.doi.org/10.2174/187221407782409134 |
Print ISSN 1872-2148 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3334 |
2
Related Articles
-
Cancer “Stemness”- Regulating MicroRNAs: Role, Mechanisms and Therapeutic Potential
Current Drug Targets A Review of Preclinical Experiments Toward Targeting M2 Macrophages in Prostate Cancer
Current Drug Targets Understanding and Applying Personalized Therapeutics at Systems Level:Role for Translational Bioinformatics
Current Pharmacogenomics and Personalized Medicine The Therapeutic Potential of Cell-Internalizing Aptamers
Current Topics in Medicinal Chemistry Development of Anti-HIV Agents Targeting Dynamic Supramolecular Mechanism: Entry and Fusion Inhibitors Based on CXCR4/CCR5 Antagonists and gp41-C34-Remodeling Peptides
Current HIV Research Recent Advances in Designing Substrate-Competitive Protein Kinase Inhibitors
Current Pharmaceutical Design Review of the Biological Activity of Maslinic Acid
Current Drug Targets Olive Oil and Cancer Risk: an Update of Epidemiological Findings through 2010
Current Pharmaceutical Design Targeting SP1 Transcription Factor in Prostate Cancer Therapy
Medicinal Chemistry Anti-Tumor Monoclonal Antibodies in Conjunction with β-Glucans: A Novel Anti- Cancer Immunotherapy
Current Medicinal Chemistry Microarray Data Integration: Frameworks and a List of Underlying Issues
Current Bioinformatics Metallodrug Conjugates with Steroids and Selective Estrogen Receptor Modulators (SERM)
Current Medicinal Chemistry A Review on the Effects of Androgen Deprivation Therapy (ADT) on Bone Health Status in Men with Prostate Cancer
Endocrine, Metabolic & Immune Disorders - Drug Targets Adopting Network Pharmacology for Cancer Drug Discovery
Current Drug Discovery Technologies Resveratrol and Prostate Cancer: The Power of Phytochemicals
Current Medicinal Chemistry Nuclear Imaging of Hormonal Receptor Status in Breast Cancer: A Tool for Guiding Endocrine Treatment and Drug Development
Current Cancer Drug Targets Activins, Myostatin and Related TGF-β Family Members as Novel Therapeutic Targets for Endocrine, Metabolic and Immune Disorders
Current Drug Targets - Immune, Endocrine & Metabolic Disorders Testosterone Deficiency in Male: A Risk Factor for Heart Failure
Endocrine, Metabolic & Immune Disorders - Drug Targets Cellular Localisation of Chromogranins and Processed Products in the Diffuse Neuroendocrine System and Related Tumours
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents How Do Microtubule-Targeted Drugs Work? An Overview
Current Cancer Drug Targets